AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05960461 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: FMF (Families Moving Forward) Connect Pro
Description: FMF Connect Pro is a program supported by mental health providers to increase access to care for children (ages 3 to 12) with fetal alcohol spectrum disorders (FASD) and their families. FMF Connect Pro teaches and supports providers in 3 main activities:~1. Routine screening of prenatal alcohol exposure (PAE)~2. Apply DSM-5 diagnostic criteria for Neurodevelopmental Disorder Associated with Prenatal Alcohol Exposure (ND-PAE)~3. Support caregivers using the FMF Connect app~FMF Connect Pro involves a Provider Dashboard with several main sections:~* Learning - includes content and additional resources to support providers in learning how to screen PAE, diagnose ND-PAE, and support families using the FMF Connect app.~* Tools and Resources - includes: screening, diagnostic, and documentation templates; app tip sheets; workbooks; supporting articles, websites, and other resources~* Clients - providers can track clients' progress using the FMF Connect app
Study NCT05960461 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ECHO (Extension of Community Healthcare Outcomes) implementation.
Description: Mental health providers participate in a 13-session tele-mentoring training program using the ECHO (Extension of Community Healthcare Outcomes) approach. Each session involves a brief didactic presentation and case-based learning using de-identified cases shared by participants. The curriculum teaches providers how to do FMF Connect Pro.
Study NCT05960461 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Self-Directed Learning implementation.
Description: Mental health providers complete 13 learning modules asynchronously on the FMF Connect Pro Dashboard. These modules include pre-recorded didactic content, brief exercises to assess learning, and additional resources. The curriculum teaches providers how to do FMF Connect Pro.
Study NCT04010890 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Culturally adapted CBT
Description: Culturally adapted CBT for South Asian Canadians
Study NCT04010890 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Culturally adapted CBT
Description: Culturally adapted CBT for South Asian Canadians
Study NCT05700955 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab and Temozolomide
Description: Characterize the safety and immunologic/genomic/metabolomic effects of neoadjuvant Pembrolizumab and Temozolomide in recurrent glioblastoma.
Study NCT05435144 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Elderberry
Description: European black elderberry extract
Study NCT05435144 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Inactive placebo
Study NCT05609916 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Cognitive Behavioral Therapy
Description: During Phase I, participants will receive open label (no blinding) CBT during their study participation for 12 to 18 weeks.~During Phase II, participants will continue receiving CBT maintenance sessions every two weeks for the first 4 weeks, followed by sessions every four weeks. They will also meet with the study physician every 2 weeks via telepsychiatry appointments for clinical and scalar assessment.
Study NCT05990582 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: CBCL
Description: A questionnaire on behaviour
Study NCT05990582 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: CBCL
Description: A questionnaire on behaviour
Study NCT05990582 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: SDQ
Description: A questionnaire on behaviour
Study NCT05990582 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: SDQ
Description: A questionnaire on behaviour
Study NCT05990582 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: CCC-2-NL
Description: A questionnaire on communcational skills
Study NCT05990582 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: CCC-2-NL
Description: A questionnaire on communcational skills
Study NCT05990582 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: MCH Feeding scale
Description: A questionnaire on feeding problems
Study NCT05990582 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: MCH Feeding scale
Description: A questionnaire on feeding problems
Study NCT05990582 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: TRF
Description: A questionnaire on behaviour
Study NCT05990582 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: TRF
Description: A questionnaire on behaviour
Study NCT05990582 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: WISC-5-NL
Description: An IQ test for children
Study NCT05990582 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: WISC-5-NL
Description: An IQ test for children
Study NCT05990582 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Movement ABC
Description: A test to assess motor function
Study NCT05990582 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Movement ABC
Description: A test to assess motor function
Study NCT05990582 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: CELF-5-NL
Description: A test to assess language development
Study NCT05990582 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: CELF-5-NL
Description: A test to assess language development
Study NCT05990582 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Emma Toolbox
Description: Test of executive functions
Study NCT05990582 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Emma Toolbox
Description: Test of executive functions
Study NCT06126874 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Patient Education
Description: Individuals in both study groups will be provided with patient education through verbal and visual presentations. In the content of patient education; information about the importance of the research topic and the content of the study through anatomical models and short animations, lifestyle recommendations for urinary incontinence symptoms (avoiding bladder irritants such as alcohol, caffeine, tea, spicy foods, acidic foods and chocolate, regulating water / fluid consumption, recommendations for attention to bowel regularity and increasing physical activity levels) and recommendations for sexual functioning (coitus positions that facilitate erection, recommendations for reshaping the sexual schema, recommendations for the physical dimension of sexual health) will be given.
Study NCT06126874 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Patient Education
Description: Individuals in both study groups will be provided with patient education through verbal and visual presentations. In the content of patient education; information about the importance of the research topic and the content of the study through anatomical models and short animations, lifestyle recommendations for urinary incontinence symptoms (avoiding bladder irritants such as alcohol, caffeine, tea, spicy foods, acidic foods and chocolate, regulating water / fluid consumption, recommendations for attention to bowel regularity and increasing physical activity levels) and recommendations for sexual functioning (coitus positions that facilitate erection, recommendations for reshaping the sexual schema, recommendations for the physical dimension of sexual health) will be given.
Study NCT06126874 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Pelvic Floor Muscle Training
Description: In PFMT, voluntary maximal and submaximal contractions for strength and endurance training of pelvic floor muscles will be taught and individuals will continue PFMT as a home exercise program. In the first 2 weeks of PFMT, individuals will perform 3 sessions of exercise per day. In each 2-week control, the number of sessions will be increased by 1 session and PFMT application will be completed with 5 sessions per day in the study.
Study NCT06126874 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pelvic Floor Muscle Training
Description: In PFMT, voluntary maximal and submaximal contractions for strength and endurance training of pelvic floor muscles will be taught and individuals will continue PFMT as a home exercise program. In the first 2 weeks of PFMT, individuals will perform 3 sessions of exercise per day. In each 2-week control, the number of sessions will be increased by 1 session and PFMT application will be completed with 5 sessions per day in the study.
Study NCT06126874 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aerobic Exercise Training
Description: Aerobic exercise training will be planned 3 days a week, 1 day on the routine clinic day with a treadmill ergometer and 2 days as a home program in the form of brisk walking outside the clinic (e.g. outdoors or in a suitable environment).The intensity of aerobic exercise training will be planned according to the Maximal Heart Rate (MHR) method and Modified Borg Scale (MBS). In the first 2 weeks in the clinic, training will be started with 50 min (+10 min warm-up and cool-down) at 60% of the MHR, the exercise intensity will be increased by 5% every 2 weeks, and the program will be terminated by providing exercise training at 85% of the MHR in the 10th-12th week. Patients will be asked to adjust the intensity of aerobic exercise outside the clinic to correspond to the 12-14 (slightly difficult) degree of perceived fatigue according to the MBS.
Study NCT06126874 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Resistance Exercise Training
Description: Resisted exercise training will be planned 2 days a week, 1 day in the clinic and 1 day outside the clinic as a home program, and 12 different exercises for large muscle groups with dumbbells and weight sets, resistance bands (therabands) will be used in the training. These exercises are leg press, leg extension, leg curl, squat, seated row, lateral pull down, biceps curl, triceps extension, dumble fly, lateral raises, bench press and abdominal crunch. Exercises will be performed with free weights (dumbbells), resistance bands (therabands) or body weight.
Study NCT05089344 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Growth Hormone
Description: growth hormone
Study NCT05089344 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Clomiphene citrate daily and recombinant FSH (Gonal-F®)
Description: Clomiphene citrate daily and recombinant FSH (Gonal-F®)
Study NCT05089344 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clomiphene citrate daily and recombinant FSH (Gonal-F®)
Description: Clomiphene citrate daily and recombinant FSH (Gonal-F®)
Study NCT06250413 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: FMT
Description: Capsulated oral auto fecal microbiota transplant
Study NCT06250413 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: FMT
Description: Capsulated oral auto fecal microbiota transplant
Study NCT06250413 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Capsulated hot chocolate powder
Study NCT06250413 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Capsulated hot chocolate powder
Study NCT06250413 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Amox Clav
Description: 5 day course of Amoxicillin Clavulanic acid given to all participants
Study NCT06250413 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amox Clav
Description: 5 day course of Amoxicillin Clavulanic acid given to all participants
Study NCT05559112 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Vitamin D-enriched mushrooms
Description: Participants will consume their usual, unrestricted, self-selected diet plus 84 g of vitamin D-enriched mushrooms twice daily (for a total of 168g per day) for 12 weeks.
Study NCT05559112 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Study Powder
Description: Participants will consume their usual, unrestricted, self-selected diet plus 1 tsp of dried study powder twice daily (2 tsp total per day) for 12 weeks. Study powder is a commercially available carbohydrate.
Study NCT05177562 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: There is no intervention in this study
Study NCT04769765 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Definition of the Individualized Care Pathway
Description: Implementation of an individualized care pathway defined in concertation with a multidisciplinary tele-expertise meeting held every 3 months for one year. These multidisciplinary tele-expertise meetings will be held between each of the normal routine consultations which are part of the normal, basic diabetic program which includes a consultation with a dietitian, monitoring by a state-registered nurse and treatment prescribed by the patient's general practitioner (with or without a consultation with the clinical pharmacist).
Study NCT04764656 — intervention group
Intervention type: DRUG
Intervention: Brolucizumab
Description: There is no treatment allocation. Patients administered Brolucizumab by prescription that have started before inclusion of the patient into the study will be enrolled.
Study NCT06041841 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LB54640
Description: LB54640 QD Oral
Study NCT06555718 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: The Peer Support Program
Description: Implementation of the research; Peer support programme for the intervention group will be carried out for 10 weeks in accordance with the peer guide-client implementation plan. Standard follow-up and training programme will be applied to the control group in accordance with the procedures of the institution.
Study NCT06555718 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Standart care
Description: The standard care provided by the institution will continue.
Study NCT05889234 — intervention group
Intervention type: DEVICE
Intervention: Modified Electroconvulsive Therapy
Description: MECT is performed using the Thymatron System IV (Somatics LLC, LakeBluff, IL, USA) electroconvulsive therapy (ECT) machine. Prior to ECT, all patients undergo laboratory tests such as routine blood, liver, kidney and thyroid function and an ECG and remain fasted for 12 hours. Initial treatment power is considered by age: percentage of power = age x 0.7. Stimulation power is adjusted according to seizure duration. If the seizure duration is less than 25 seconds, the energy is increased by 5% in the subsequent treatments. Anaesthesia and muscle relaxation were administered with propofol (1.5-2 mg/kg) and succinylcholine (0.5-1 mg/kg), respectively, and subjects were awakened after ECT treatment and adverse effects, such as subjective memory impairment, headache or nausea/vomiting, were recorded. Frequency of ECT treatment: 3-4 times per week for a total of 6-8 sessions
Study NCT05889234 — intervention group
Intervention type: DRUG
Intervention: Conventional pharmacotherapy
Description: Conventional pharmacotherapy: SSRIs including fluoxetine, paroxetine, sertraline, cetinopram, fluvoxamine, vortioxetine, escitalopram; SNRIs including venlafaxine, duloxetine; NaSSA including mirtazapine; other antidepressants including trazodone, bupropion, agomelatine; potentiators including aripiprazole, olanzapine, quetiapine, risperidone.
Study NCT06216158 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Iberdomide
Description: Iberdomide p.o. (1.0 mg, day 1-21 of each 29-days cycle)
Study NCT06216158 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Iberdomide
Description: Iberdomide p.o. (1.0 mg, day 1-21 of each 29-days cycle)
Study NCT06216158 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Isatuximab
Description: Isatuximab s.c. (1400 mg, cycle 1: day 1, 8, 15, 22; cycles 2-3: day 1 and 15; from C4: day 1)
Study NCT05264870 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Norepinephrine
Description: treatment of postspinal hypotension
Study NCT05081024 — intervention group
Intervention type: PROCEDURE
Intervention: Biopsy
Description: Undergo biopsy
Study NCT05081024 — intervention group
Intervention type: PROCEDURE
Intervention: Biospecimen Collection
Description: Undergo collection of blood and/or tissue samples
Study NCT05081024 — intervention group
Intervention type: OTHER
Intervention: Electronic Health Record Review
Description: Medical records are reviewed
Study NCT05578235 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: stapled side-to-side anastomosis
Description: Standard procedure for CD
Study NCT05578235 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Handsewn anastomosis
Description: handsewn end-to-end or Kono-s anastomosis
Study NCT05081999 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Medical Assessment
Description: medical hx, events inquiry, adherence to treatment arm periodically over 4 years
Study NCT06502197 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Silastic Stenting
Description: Drill-out frontal sinus procedures, are a well-established surgical intervention in the management of CRS, involves extensive sinus surgery with the creation of a large, surgically exposed area of raw bone. This raw bone, left exposed postoperatively, poses a unique challenge in the context of mucosal healing. Silastic stents, inserted into the sinus cavities, offer a promising solution by providing structural support and facilitating mucosal re-mucolisation in this critical period of postoperative recovery.
Study NCT05081999 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Quality of Life Assessment
Description: online questionnaires periodically over 4 years, including SAQ, EQ-5D-5L, IIEF-5 (males) or FSFI (females)
Study NCT05048706 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Laser lithotripsy (SP TLF)
Description: Laser lithotripsy of urinary calculi using the Super Pulse Thulium fiber laser (SP TLF)
Study NCT05048706 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Laser lithotripsy (Ho:YAG)
Description: Laser lithotripsy of urinary calculi using the standard Holmium: Yttrium-Aluminium-Garnet (Ho:YAG) laser.
Study NCT06390254 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Resilience-Enhancing Nursing Suppor
Description: The resilience-building nursing intervention in this study is a multifaceted approach aimed at enhancing the psychological well-being and coping abilities of community-dwelling older adults. Unlike standard care, which typically focuses on symptom management, this intervention emphasizes proactive strategies to promote resilience and improve overall quality of life.
Study NCT04764409 — intervention group
Intervention type: PROCEDURE
Intervention: Chemoembolization
Description: Transarterial Chemoembolization (TACE)
Study NCT04764409 — intervention group
Intervention type: PROCEDURE
Intervention: Chemoinfusion
Description: Transarterial Infusion (TAI)
Study NCT06216158 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexamethasone
Description: Dexamethasone p.o. or i.v. (20 mg, cycle 1 only: day 1, 8, 15, 22)
Study NCT05754229 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: AI-assisted colonoscopy
Description: The patients will receive an AI-assisted colonoscopy (AIC) using the computer-aided polyp detection and characterization (CADe and CADx) GI Genius (Medtronic).
Study NCT04960319 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intravascular Lithotripsy
Description: Coronary Angiography. When the anatomic inclusion criteria are met, traverse the lesion with a guidewire. If traversal fails, assign the subject to the registry. After wire traversal has been documented by cine angiography, angiographic, OCT-defined or balloon expansion criteria are met, subject is enrolled. Blood sample for Troponin (hs TnT) baseline measurement has to be taken. The subjects will be randomized in a 1:1 fashion to treatment with either IVL or RA.
Study NCT04960319 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Intravascular Lithotripsy
Description: Coronary Angiography. When the anatomic inclusion criteria are met, traverse the lesion with a guidewire. If traversal fails, assign the subject to the registry. After wire traversal has been documented by cine angiography, angiographic, OCT-defined or balloon expansion criteria are met, subject is enrolled. Blood sample for Troponin (hs TnT) baseline measurement has to be taken. The subjects will be randomized in a 1:1 fashion to treatment with either IVL or RA.
Study NCT04754334 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ORMD-0801
Description: Oral Insulin
Study NCT04754334 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Fish Oil
Study NCT06216158 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Dexamethasone p.o. or i.v. (20 mg, cycle 1 only: day 1, 8, 15, 22)
Study NCT06358287 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: cryogenic auriculotherapy
Description: Compressed nitrogen is used to create a 'cryonic needle', using a cryopunctor device. An orifice is placed in appropriate acupoint and nitrogen flow is used to cool and activate the point.
Study NCT04132401 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: algorithm
Description: The diagnostic capacity of the algorithm will be compared with that of the family medicine physicians and with retina specialists. The reference will be a blinded double reading conducted by the retina specialists
Study NCT05886478 — intervention group
Intervention type: DRUG
Intervention: No intervention
Description: As this is an observational study, no intervention will be administered.